Stanford University researchers used 61 inmates ranging in age from 14 to 18 at a California Youth Authority (CYA) correctional center in an experiment testing the psychotropic drug, Depakote.
Tune in tonight–Monday– to Court TV: the subject is medical experimentation on prisoners–What does this say about our moral climate?
Congressional leaders have lost patience with the cat and mouse game being played by officials of the National Institutes of Health.
8, 362 consumers of Lilly’s top-selling drug that produces diabetes–among other life-threatening effects–can expect between $5,000 to "well over $100,000 a person" depending upon the harm suffered.
Every federal oversight agency evaluating FDA’s safety performance has given the agency flunking grades. See:https://ahrp.stagenoises.ch/cms/content/view/148/55/
The Times’ humorous profile of JAMA’s editor attempts to trivialize the threat to public health when journals fail to maintain the integrity of science-based medicine.
The harm done by journals’ failure to protect the integrity of science can hardly be overstated.
The full impact on six healthy volunteers who took part in a catastrophic experiment that nearly killed them is ever so slowly coming to light.
The American Society of Health System Pharmacists reports that the FDA "directed all makers of ADHD stimulants in May to strengthen the wording in the "Warnings" section of the labeling "with regard to serious cardiovascular events and psychiatric events."
The law firm of Baum Hedlund filed a lawsuit against GlaxoSmithKline, the maker of the antidepressant, Paxil, for causing severe heart defects in the newborn son, of a woman prescribed Paxil during her pregnancy.
Antidepressants involved in three suicides: 19-year old Chess Prodigy; 50-year old lawyer; 11-year old child
Today’s New York Times editorial hits the mark–it’s right on target!
